A polymorphic modifier gene alters the hypertrophic response in a murine model of familial hypertrophic cardiomyopathy

Journal of Molecular and Cellular Cardiology

Volumn 33, Issue 11, 2001, Pages 2055-2060

  Semsarian, Christopher ^a   Healey, Michael J ^a   Fatkin, Diane ^a   Giewat, Michael ^a   Duffy, Catherine ^a   Seidman, Christine E ^a,b   Seidman, J G ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cardiomyopathy; Familial; Genetic modifier; Heterogeneity; Sarcomere

Indexed keywords

MYOSIN HEAVY CHAIN;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CONTROLLED STUDY; DNA MODIFICATION; FAMILIAL DISEASE; GENE EXPRESSION; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE WALL; HYPERTROPHIC CARDIOMYOPATHY; INBRED STRAIN; MISSENSE MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECESSIVE INHERITANCE; SARCOMERE; STRAIN DIFFERENCE;

MURINAE;

EID: 0035201270     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.2001.1466     Document Type: Article

References (20)

1. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults
2. Prognostic implications of left ventricular hypertrophy
3. Extreme left ventricular hypertrophy
4. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy
5. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy
6. Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass
7. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death
8. Lack of association of polymorphisms of the angiotensin converting enzyme and angiotensinogen genes with nonfamilial hypertrophic or dilated cardiomyopathy
9. AT1 receptor A/C1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy
10. Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy
11. A mouse model of familial hypertrophic cardiomyopathy
12. Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy
13. Comparison of two murine models of familial hypertrophic cardiomyopathy
14. The pathogenesis of familial hypertrophic cardiomyopathy: Early and evolving effects from an alpha-cardiac myosin heavy chain missense mutation
15. Black swiss outbred mice
16. An abnormal Ca2 + response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy
17. A comparative study of various tests for normality
18. Idiopathic hypertrophic cardiomyopathy in identical twins. Morphological heterogeneity of the left ventricle
19. Identical male twins showing progression from hypertrophic cardiomyopathy to dilated cardiomyopathy-like features